Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

CACTI
13F-HR - CACTI ASSET MANAGEMENT LLC (0001452208) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by CACTI ASSET MANAGEMENT LLC....

Our
Bond Reports Positive Pipeline Momentum After GSX and Approves 1-for-20 Reverse Split

The company cites strong follow-up leads from GSX 2026 and cites high local government adoption, while announcing a board-approved reverse stock split...

Vir
Vir Biotechnology appoints Aziz Sawaf as CFO

Vir Biotechnology named Aziz Sawaf as EVP and CFO, replacing the outgoing officer. With 20 years of biopharma experience, Sawaf is expected to strengt...

AVAX
AVAX One Tech Repurchases 333,500 Shares

The company repurchased 333,500 shares at an average price of $5.36 in September 2026; the announcement underscores management's confidence in the sto...

CION
CION to report Q3 2026 earnings on Nov. 5

CION Investment Corporation announced it will report Q3 2026 results on Thursday, Nov. 5, and host an earnings conference call at 11:00 a.m. ET....

Agassi
Agassi's Sports Forms Racket Sports Subsidiary

Agassi Sports Entertainment Corp. formed wholly-owned subsidiary 'Let's Play' and appointed Jonathan Fornaci as President to build a global network an...

BATTALION
Battalion Oil Appoints Brad Juneau to Board of Directors

Battalion Oil announced the appointment of Brad Juneau, an independent director with decades of energy experience. This expansion strengthens the Boar...

MINERALS
Minerals Technologies Announces $400 Million Senior Notes Offering

MTI is offering $400 million of senior notes due 2034 to redeem outstanding 2028 notes and pay related fees....

Banzai
Banzai International Signs Stock Subscription Agreement

Banzai International entered a subscription agreement with Joe Davy to sell 115,965 shares at $0.70 per share in a private financing transaction....

BNB
BNB Plus amends registration rights agreement effective Sept. 28, 2026

BNB Plus Corp. amended its Registration Rights Agreement to replace mandated registration with demand-only rights and withdrew its S-1 registration st...

PARKERVISION
Federal Circuit remands patent case back to district court

The Court of Appeals for the Federal Circuit dismissed Qualcomm's appeal due to a lack of jurisdiction, allowing ParkerVision to proceed with a jury t...

SpyGlass
SpyGlass Pharma Acquires Advanced Vision Science for $13M

Buyout secures scalable IOL manufacturing capacity for lead product candidate BIM-IOL System and accelerates premium lens portfolio expansion. Wed Aug...

Orchestra
Orchestra BioMed snaps up full enrolment in Medtronic's BACKBEAT trial

Orchestra BioMed has surpassed its target of 316 patients in the pivotal BACKBEAT trial. Full enrollment positions the company to submit primary endpo...

FIRST
First Merchants Corp says CEO Mark Hardwick will retire in 2026

First Merchants Corp announced that CEO Mark Hardwick will retire at year-end and will be succeeded by President Mike Stewart, effective Jan. 1, 2027....

Azitra,
Azitra Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2

Azitra announced the completion of Cohort 1 and clearance for Cohort 2 of a clinical trial evaluating drug candidate ATR04-484 as a treatment for EGFR...

Aptera
Aptera Cuts Capital Needs for Production by Nearly 40%

Aptera Motors significantly reduced its estimated capital requirements to reach production to approximately $25 million and approx $115 million with t...

Evommune,
Evommune shares phase 2a AD data for EVO301

The executive highlighted EVO301's Phase 2a success and initial dosing data, with plans to launch a Phase 2b trial in mid-2027....

Allarity
Allarity strengthens DRP strategy with new patents and lab capabilities

Allarity received recent patent awards and CLIA certification to retain exclusive control of its Drug Response Predictor test for stenoparib, aiding i...

RADNOSTIX
Radnostix executes asset purchase agreement

Radnostix, the parent company formerly known as International Isotopes, signed an asset purchase agreement with Nano Nuclear Energy and Haleu Energy F...

NEKTAR
Rezpegaldesleukin shows over 6-month off-treatment durability in alopecia areata

Nektar Therapeutics announced long-term data for rezpegaldesleukin at EADV 2026, showing durable hair regrowth after treatment cessation and initiatio...